J&J Subsidiaries Fight Back Generic Challenge

Law360, New York (July 7, 2006, 12:00 AM EDT) -- Subsidiaries of Johnson & Johnson are suing a generic drug maker for patent infringement, hoping to block its attempts to market a generic version of a drug used to treat Alzheimer’s disease.

Janssen Pharmaceutica N.V., Janssen L.P., Ortho-McNeil Neurologics Inc. and Synaptech Inc. filed the lawsuit against Barr Pharmaceuticals and its subsidiary, Barr Laboratories Inc., a Delaware corporation that operates in New Jersey.

The lawsuit was triggered when Barr filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration for a generic...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.